• Vicinium Granted Fast Track Designation by FDA americanpharmaceuticalreview
    August 13, 2018
    Sesen Bio announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Vicinium for the treatment of BCG-unresponsive high-grade non-muscle invasive bladder cancer (NMIBC). Vicinium......
PharmaSources Customer Service